Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of femoral head osteonecrosis after initial corticosteroid therapy in systemic lupus erythematosus
jRCTs071180052Recruiting
- Start
- Dec 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of clopidogrel, pitavastatin and tocopherol in osteonecrosis of the hip and systemic lupus erythematosus (SLE). Primary endpoint: Incidence of osteonecrosis of the femoral head. Started Dec 2014; status: recruiting.
02
Drugs
clopidogrelpitavastatintocopherol
03
Conditions
osteonecrosis of the hipsystemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on jRCTs071180052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180052.